Thromboelastography and recombinant factor VIIa—hemophilia and beyond
- 1 January 2004
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 41, 140-144
- https://doi.org/10.1053/j.seminhematol.2003.11.024
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- How factor VIIa works in hemophiliaJournal of Thrombosis and Haemostasis, 2003
- Influence of Factor VIIa and Phospholipids on Coagulation in “Acquired” HemophiliaArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Reversal of Warfarin-Induced Excessive Anticoagulation with Recombinant Human Factor VIIa ConcentrateAnnals of Internal Medicine, 2002
- Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouseNature Medicine, 2002
- Mechanism of factor VIIa–dependent coagulation in hemophilia bloodBlood, 2002
- Recombinant factor VIIa (NovoSeven®) as a hemostatic agentSeminars in Hematology, 2001
- Efficacy and Safety of Recombinant Factor VIIa in the Prophylaxis of Bleeding in Various Surgical Procedures in Hemophilic Patients with Factor VIII and Factor IX InhibitorsSeminars in Thrombosis and Hemostasis, 2000
- Management and monitoring of recombinant activated factor VIIBlood Coagulation & Fibrinolysis, 2000
- The effect of recombinant factor VIIa (NovoSeven???) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0Blood Coagulation & Fibrinolysis, 1998
- Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIIIThe Lancet, 1991